- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02374528
Negative Pressure Wound Therapy for Skin Grafts
February 13, 2019 updated by: Zhu Jiayuan, First Affiliated Hospital, Sun Yat-Sen University
Clinical Randomized Controlled Trials on Negative Pressure Wound Therapy for Skin Grafts
The repairing of various wounds is always a great challenge in burn surgery and plastic surgery.
Skin-grafting is the main therapy.
Bolster dressings are traditionally applied to secure the graft to the wound bed, however, there is some evidence to show that irregularly contoured recipient sites, poorly healing areas, reduce the success rate of skin-grafting with traditional bolster dressings, increasing morbidity, pain.
Negative pressure wound therapy has been advocated as a potential solution to some of these issues.
To further test the healing rate and safety of this new method, the investigators propose a prospective randomized controlled trial to compare this method with traditional bolster dressings application in skin-grafting.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The repairing of various wounds is always a great challenge in burn surgery and plastic surgery.
Skin-grafting is the main therapy.
Bolster dressings are traditionally applied to secure the graft to the wound bed, however, there is some evidence to show that irregularly contoured recipient sites, exuding wounds, poorly healing areas, and the presence of shear stress significantly reduce the success rate of skin-grafting with traditional bolster dressings, increasing morbidity, pain, hospital stay, and cost.
Negative pressure wound therapy (NPWT) has been advocated as a potential solution to some of these issues.
the application of NPWT to skin-grafting may promote blood flow and microcirculation to the graft bed, reduction of edema, exudates, and hematomas, and result in significant qualitative improvement in split skin graft take.
To further test the healing rate and safety of this new method, the investigators propose a prospective randomized controlled trial to compare this method with traditional bolster dressings application in skin-grafting.
Study Type
Interventional
Enrollment (Actual)
98
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 85 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects who need to skin graft to repair the wound
- Subjects signed the informed consent in the day of the age of not more than 85 years old (for minors, legal guardian should be signed)
- Stable vital signs, regular examination showed that subjects could tolerate surgery
- Subjects' mental state are good, could follow the doctor's advice, visit on a regular basis
- Understanding and willing to participate in this clinical trial and signed informed consent
- All women subjects must agree to take effective contraceptive measures in the six months study period, and without pregnancy before participate in the treatment
- No other serious diseases conflicts with the trail
Exclusion Criteria:
- Allergic constitution of negative pressure dressing
- Severe uncontrolled disease or acute systemic infections and complication with other serious heart, lung disease, encephalopathy and other organs or have a rapid progress or terminal disease
- Subjects with mental illness
- Subjects could not cooperate with the clinical trial personnel to finish trials
- Existing disease (malignant tumor, autoimmune disease) or require the use of drugs (high-dose glucocorticoids, which is defined as accepting 40 mg or more daily prednisone or prednisone amount, period of two weeks or more) will affect the healing of the wound
- For HIV positive patients, clinical diagnosis of patients with AIDS or the screening phase of neutrophil count (ANC) absolutely < 1000 cells/mm3
- Subjects could not tolerate surgery
- Subjects are unlikely to survive in the study period
- The investigators think that who should not be included
- Subjects are in or participated in other clinical researchers over the past 12 weeks
- Subjects are participated in this trial at any time in the past
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Negative pressure wound therapy
Negative pressure wound therapy (NPWT) is the application of suction (negative pressure) to wounds with skin grafting.
|
Negative pressure wound therapy (NPWT) is the application of suction (negative pressure) to wounds with skin grafting.
|
|
Active Comparator: standard pressure bolster dressing
This method is traditional used in skin grafting wound.
|
This method is traditional used in skin grafting wound.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
healing rate (the percentage of subjects that achieved complete wound closure, complete wound closure is defined as skin complete reepithelialization without drainage or dressing requirements)
Time Frame: postsurgery week 4
|
the percentage of subjects that achieved complete wound closure, complete wound closure is defined as skin complete reepithelialization without drainage or dressing requirements.
|
postsurgery week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VAS pain grade
Time Frame: postsurgery week 4
|
assess the pain of the wound at each visit time
|
postsurgery week 4
|
|
Skin graft survival rate
Time Frame: postsurgery week 2
|
The area of the skin graft has been survival percentage accounted for the entire
|
postsurgery week 2
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jiayuan Zhu, doctor, First Affiliated Hospital, Sun Yat-Sen University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2015
Primary Completion (Actual)
December 1, 2018
Study Completion (Actual)
December 1, 2018
Study Registration Dates
First Submitted
February 23, 2015
First Submitted That Met QC Criteria
February 27, 2015
First Posted (Estimate)
March 2, 2015
Study Record Updates
Last Update Posted (Actual)
February 15, 2019
Last Update Submitted That Met QC Criteria
February 13, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 2015046
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Transplantation
-
University Children's Hospital, ZurichUniversity of Zurich; Kantonsspital Aarau; Kantonsspital Winterthur KSWRecruiting
-
UPM BiomedicalsHelsinki University Central HospitalTerminatedSkin TransplantationFinland
-
UPM BiomedicalsUniversity of HelsinkiCompleted
-
University Children's Hospital, ZurichUniversity of Zurich; Swiss National Science Foundation; Centre Hospitalier Universitaire...Not yet recruitingFull Thickness Skin Defects | Burn Degree Second | Burn Degree Third | Skin TransplantationSwitzerland
-
LAMB ProjectCompletedWounds and Injuries | Skin Transplantation | Antibiotic Prophylaxis SurgeryBangladesh
-
University Hospital, CaenCompleted
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Intestine TransplantationBelgium, Germany, Italy, Poland, United Kingdom, Czechia, France
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedStudy Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant RecipientsKidney Transplantation | Skin NeoplasmsAustralia, United States, Canada, New Zealand
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedKidney Transplantation | Renal Transplantation | Transplantation, Kidney | Grafting, Kidney | Transplantation, RenalBelgium, Germany, Spain, Sweden, Italy, Switzerland, United Kingdom, Austria, France, Poland, Czech Republic, Netherlands
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationSpain, Australia, France, Germany, Canada, Italy, United Kingdom, Belgium, South Africa, Switzerland, Sweden, United States, Austria, Brazil, Czechia, Denmark, Finland, Hungary, Ireland, Mexico, Netherlands, New Zealand, Poland
Clinical Trials on Negative pressure wound therapy
-
ConvaTec Inc.WithdrawnSurgical Wound, Recent | Trauma-related Wound | Dehiscence Wound | Surgical Wound LeakUnited States
-
Sindh Institute of Urology and TransplantationCompletedSurgical Site Infection | Wound Heal | Negative-Pressure Wound Therapy | Stoma Site InfectionPakistan
-
Henry Ford Health SystemWithdrawnSurgical Site Infection | Groin InfectionsUnited States
-
Region SkaneRecruitingPostoperative Complications | Surgical Wound Infection | Skin Cancer | Wound Healing | Bandages | Negative-Pressure Wound Therapy | Skin Grafting | Lower Extremity | Skin Transplantation | Split Thickness Skin Graft | Skin Tumour | LegSweden
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingSurgical Wound InfectionUnited States
-
Murk NiazCompletedSurgical Site Infection | Hepatobiliary Disease | Hepatobiliary DisordersPakistan
-
Zuyderland Medisch CentrumCompletedBreast Cancer | Wound Infection | Wound Complication | Wound Dehiscence | Wound NecrosisNetherlands
-
Royal College of Surgeons, IrelandRecruitingWound Healing | Pilonidal SinusIreland
-
Zuyderland Medisch CentrumRecruitingBreast Cancer | Seroma | Wound ComplicationNetherlands